Dusa Pharmaceuticals (DUSA) reports preliminary results of Phase II clinical trials...

|About: DUSA Pharmaceuticals, Inc. (DUSA)|By:, SA News Editor

Dusa Pharmaceuticals (DUSA) reports preliminary results of Phase II clinical trials investigating the use of the Levulan Kerastick in conjunction with BLU-U blue light illumination for the treatment of actinic keratoses of the face and scalp when utilizing short drug incubation. The study demonstrated that treatment — after incubating for one, two or three hours — resulted in a statistically significant number of patients with complete lesion clearance and a statistically significant reduction in AK lesion count.